Record Q1 lifts Nordson (NASDAQ: NDSN) sales, EPS and 2026 outlook

Rhea-AI Filing Summary

Nordson Corporation reported record first quarter fiscal 2026 results and raised its full-year outlook. Sales reached $669 million, up about 9% from $615 million a year earlier, driven by 7% organic growth and favorable currency.

Net income rose to $133 million, with diluted earnings per share increasing to $2.38 from $1.65, a 44% gain helped by a non-cash gain on a minority investment. Adjusted diluted EPS, which excludes this gain and acquisition-related amortization, was a record $2.37, up 15% from $2.06.

EBITDA was also a first quarter record at $203 million, representing 30% of sales. Advanced Technology Solutions led growth with 23% higher sales and a 43% increase in EBITDA, while backlog grew approximately 4% year-over-year. The company now expects full-year sales of $2,860 to $2,980 million and adjusted EPS of $11.00 to $11.60, and forecasts second quarter sales of $710 to $740 million and adjusted EPS of $2.70 to $2.90.

Positive

• Record earnings and raised guidance: Q1 2026 sales grew to $669 million with adjusted EPS up 15% to $2.37, backlog increased ~4%, and management raised full-year sales guidance to $2,860–$2,980 million and adjusted EPS guidance to $11.00–$11.60.

Negative

• None.

Insights

Equity Analyst

Record Q1 growth and higher 2026 guidance signal broadly strong operating momentum.

Nordson delivered a record fiscal Q1 with sales of $669 million, up 8.8%, and diluted EPS of $2.38, up 44%. Adjusted EPS of $2.37 rose 15%, indicating underlying profit growth beyond the non-cash investment gain.

Segment data show especially robust performance in Advanced Technology Solutions, where sales grew 23% and EBITDA rose 43%, reflecting strong electronics dispense and recovering x-ray demand. Industrial Precision Solutions also grew 9%, and Medical and Fluid Solutions improved profitability despite flat sales.

Backlog increased about 4%, supporting management’s decision to lift guidance. The company now targets full-year sales of $2,860–$2,980 million and adjusted EPS of $11.00–$11.60, with Q2 sales guided to $710–$740 million and adjusted EPS to $2.70–$2.90. Subsequent quarterly reports will show how well orders and margins track these higher ranges.

false000007233100000723312026-02-182026-02-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 18, 2026

NORDSON CORPORATION

(Exact Name of Registrant as Specified in its Charter)

Ohio			000-07977			34-0590250
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification Number)

28601 Clemens Road

Westlake, Ohio 44145

(Address of Principal Executive

Offices, including Zip Code)

Registrant’s Telephone Number, including Area Code: 440-892-1580

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange On Which Registered

Common Shares, without par value

NDSN

Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933(§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.    Results of Operations and Financial Condition.

On February 18, 2026, Nordson Corporation issued a press release relating to its results of operations for the first quarter of fiscal 2026. A copy is attached as Exhibit 99.1.

Item 7.01.    Regulation FD Disclosure.

Nordson Corporation will provide additional commentary on first quarter fiscal 2026 results and outlook during a webcast on Thursday, February 19, 2026 at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. For persons unable to listen to the live broadcast, a replay will be available after the event.

As provided in General Instruction B.2 of Form 8-K, the information contained in Items 2.02 and 7.01 of this Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall any such information be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01    Financial Statements and Exhibits.

(d) Exhibits.

99.1						Press release of Nordson Corporation dated February 18, 2026.
104						Cover Page Interactive Data File (embedded within the inline XBRL document).

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

						NORDSON CORPORATION
Date:			February 18, 2026			By:			/s/ Joseph Rutledge
									Joseph Rutledge
									Chief Accounting Officer

Nordson Corporation Reports Record First Quarter Fiscal 2026 Results and Increases Full Year Guidance

First Quarter Highlights:

•Sales were a first quarter record of $669 million, an increase of 9% year-over-year

•Earnings per diluted share were $2.38, up 44% year-over-year

•Adjusted earnings per diluted share were $2.37, a first quarter record and up 15% year-over-year

•Backlog grew approximately 4% year-over-year

•Increasing full year guidance for sales and earnings

WESTLAKE, Ohio--(BUSINESS WIRE)--February 18, 2026--Nordson Corporation (Nasdaq: NDSN) today reported results for the fiscal first quarter ended January 31, 2026. Sales were a first quarter record of $669 million compared to the prior year’s first quarter sales of $615 million. The first quarter 2026 sales included an organic sales increase of 7% and a favorable currency translation impact of 4%, which was slightly offset by the medical contract manufacturing divestiture completed in the fourth quarter of last year.

Net income was $133 million, or $2.38 of earnings per diluted share, compared to prior year’s first quarter net income of $95 million, or $1.65 of earnings per diluted share. First quarter 2026 earnings benefited from a non-cash gain on a minority technology investment recognized during the quarter. Excluding the non-cash gain and acquisition-related amortization, first quarter adjusted earnings per diluted share were a record $2.37, a 15% increase from the prior year adjusted earnings per diluted share of $2.06.

EBITDA was also a first quarter record of $203 million or 30% of sales, an increase of 8% compared to prior year EBITDA of $188 million, or 31% of sales.

Commenting on the Company’s fiscal 2026 first quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “Our proprietary technology portfolio, close to the customer business model and Ascend strategy have positioned us well to win in our inflecting end markets, particularly in the semiconductor space. We delivered organic growth in all our segments, as well as solid margin and cash flow. This strong first quarter performance has set the stage well for fiscal 2026.”

First Quarter Segment Results

Industrial Precision Solutions sales of $327 million increased 9% from the prior year, inclusive of an organic sales increase of 3% and favorable currency translation of 6%. The organic sales increase was driven by balanced growth across most product lines, with particular strength in Asia Pacific markets. EBITDA in the quarter was $110 million, or 34% of sales, compared to prior year first quarter EBITDA of $113 million.

Medical and Fluid Solutions sales of $193 million were flat compared to the prior year first quarter, inclusive of an organic sales increase of 3% and a favorable currency impact of 1%, which was offset by 4% related to the previously divested medical contract manufacturing business. The organic sales increase was driven by growth in engineered fluid solution product lines. EBITDA in the quarter was $70 million, or 36% of sales, up 9% versus the prior year first quarter EBITDA of $64 million.

Advanced Technology Solutions sales of $149 million increased 23% compared to the prior year first quarter, inclusive of an organic sales increase of 21% and favorable currency translation of 2%. The organic sales increase compared to prior year was driven by ongoing growth in electronics dispense systems and recovering demand for x-ray systems. EBITDA in the quarter was $33 million, or 22% of sales, up 43% from the prior year first quarter EBITDA of $23 million.

Outlook

The Company enters the second quarter with increased backlog, up approximately 4% over the prior year. Order entry momentum was broad-based in the quarter with particular strength in our ATS segment. These trends position the Company to

1

deliver second quarter fiscal 2026 sales in the range of $710 to $740 million. Second quarter adjusted earnings are forecasted to be in the range of $2.70 to $2.90 per diluted share.

Based on the strong start to the year, the second quarter outlook and the current foreign exchange rate environment, the Company is increasing its full year guidance. Sales are now expected to be in the range of $2,860 to $2,980 million and adjusted earnings to be in the range of $11.00 to $11.60 per diluted share.

Reflecting on the full year outlook, Mr. Nagarajan said, “At the start of the year, we indicated that several of our key end markets had begun to inflect, and I am proud of our teams for delivering such a strong first quarter. We have growing confidence in our full year based on strengthening backlog and order entry, which is reflected in our increased annual guidance range. We remain focused on serving our customers and returning value to our shareholders.”

Nordson management will provide additional commentary on these results and outlook during its previously announced webcast on Thursday, February 19, 2026, at 8:30 a.m. eastern time, which can be accessed at https://investors.nordson.com. Information about Nordson’s investor relations and shareholder services is available from Lara Mahoney, vice president, investor relations and corporate communications at (440) 204-9985 or lara.mahoney@nordson.com.

Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as “may,” “will,” “should,” “could,” “expects,” “anticipates,” “believes,” “projects,” “forecasts,” “outlook,” “guidance,” “continue,” “target,” or the negative of these terms or comparable terminology. These statements reflect management’s current expectations and involve a number of risks and uncertainties. These risks and uncertainties include, but are not limited to, U.S. and international economic and political conditions; financial and market conditions; currency exchange rates and devaluations; possible acquisitions and the Company’s ability to successfully integrate acquisitions; the Company’s ability to successfully divest or dispose of businesses that are deemed not to fit with its strategic plan; the effects of changes in U.S. trade policy and trade agreements, including changes in tariffs by the U.S. or other nations; the effects of changes in tax law; and the possible effects of events beyond our control, such as political unrest, including the conflicts in Europe and the Middle East, acts of terror, natural disasters and pandemics and the other factors discussed in Item 1A (Risk Factors) in the Company’s most recently filed Annual Report on Form 10-K and in its Forms 10-Q filed with the Securities and Exchange Commission, which should be reviewed carefully. The Company undertakes no obligation to update or revise any forward-looking statement in this press release.

Nordson Corporation is an innovative precision technology company that leverages a scalable growth framework through an entrepreneurial, division-led organization to deliver top tier growth with leading margins and returns. The Company’s direct sales model and applications expertise serve global customers through a wide variety of critical applications. Its diverse end market exposure includes consumer non-durable, medical, electronics and industrial end markets. Founded in 1954 and headquartered in Westlake, Ohio, the Company has operations and support offices in over 35 countries. Visit Nordson on the web at www.nordson.com, linkedin/Nordson, or www.facebook.com/nordson.

2

NORDSON CORPORATION

SEGMENT INFORMATION (Unaudited)

(Dollars in thousands)

			Three Months Ended
			January 31, 2026												January 31, 2025
SALES
Industrial Precision Solutions			$	326,861											$	300,448
Medical and Fluid Solutions			193,183												193,609
Advanced Technology Solutions			149,417												121,363
Total sales			$	669,461											$	615,420
EBITDA
Industrial Precision Solutions			$	110,311					34%						$	112,776					38%
Medical and Fluid Solutions			70,206						36%						64,332						33%
Advanced Technology Solutions			32,600						22%						22,771						19%
Corporate expenses			(10,127)												(11,776)
Total EBITDA (non-GAAP) (1)			$	202,990					30%						$	188,103					31%

(1) Total company EBITDA is a non-GAAP measure. Refer to the reconciliation of non-GAAP measures – net income to EBITDA.

3

NORDSON CORPORATION

CONSOLIDATED STATEMENTS OF INCOME (Unaudited)

(Dollars in thousands except for per-share amounts)

			Three Months Ended
			January 31, 2026						January 31, 2025
Sales			$	669,461					$	615,420
Cost of sales			303,339						279,524
Gross profit			366,122						335,896
Gross margin %			54.7		%				54.6		%
Selling and administrative expenses			199,717						194,949
Operating profit			166,405						140,947
Interest expense — net			(22,741)						(25,618)
Other income — net			20,837						1,526
Income before income taxes			164,501						116,855
Income taxes			31,119						22,203
Net income			$	133,382					$	94,652
Weighted-average common shares outstanding:
Basic			55,789						57,129
Diluted			56,127						57,486
Earnings per share:
Basic earnings			$	2.39					$	1.66
Diluted earnings			$	2.38					$	1.65

4

NORDSON CORPORATION

CONSOLIDATED BALANCE SHEETS (Unaudited)

(Dollars in thousands)

			January 31, 2026						October 31, 2025
Cash and cash equivalents			$	120,392					$	108,442
Receivables — net			571,583						587,843
Inventories — net			451,138						444,814
Other current assets			108,558						101,752
Total current assets			1,251,671						1,242,851
Property, plant and equipment - net			521,508						516,914
Goodwill			3,332,244						3,304,685
Other assets			855,499						853,231
			$	5,960,922					$	5,917,681
Notes payable and debt due within one year			$	54,312					$	315,000
Accounts payable and accrued liabilities			405,737						443,260
Total current liabilities			460,049						758,260
Long-term debt			1,943,182						1,681,254
Other liabilities			445,585						434,596
Total shareholders' equity			3,112,106						3,043,571
			$	5,960,922					$	5,917,681

5

NORDSON CORPORATION

CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited)

(Dollars in thousands)

			Three Months Ended
			January 31, 2026						January 31, 2025
Cash flows from operating activities:
Net income			$	133,382					$	94,652
Depreciation and amortization			36,585						37,031
Other non-cash items			(11,675)						3,160
Changes in operating assets and liabilities and other			(17,864)						24,279
Net cash provided by operating activities			140,428						159,122
Cash flows from investing activities:
Additions to property, plant and equipment			(17,513)						(21,399)
Other — net			(158)						7,123
Net cash used in investing activities			(17,671)						(14,276)
Cash flows from financing activities:
Issuance (repayment) of long-term debt			2,367						(22,563)
Repayment of finance lease obligations			(1,616)						(1,320)
Dividends paid			(45,786)						(44,602)
Issuance of common shares			18,795						1,001
Purchase of treasury shares			(86,001)						(60,098)
Net cash used in financing activities			(112,241)						(127,582)
Effect of exchange rate change on cash:			1,434						(2,792)
Net change in cash and cash equivalents			11,950						14,472
Cash and cash equivalents:
Beginning of period			108,442						115,952
End of period			$	120,392					$	130,424

6

NORDSON CORPORATION

SALES BY GEOGRAPHIC SEGMENT (Unaudited)

(Dollars in thousands)

			Three Months Ended												Sales Variance
			January 31, 2026						January 31, 2025						Organic						Acquisitions / Divestitures						Currency						Total
SALES BY SEGMENT
Industrial Precision Solutions			$	326,861					$	300,448					3.2		%				—		%				5.6		%				8.8		%
Medical and Fluid Solutions			193,183						193,609						2.7		%				(4.3)		%				1.4		%				(0.2)		%
Advanced Technology Solutions			149,417						121,363						20.7		%				—		%				2.4		%				23.1		%
Total sales			$	669,461					$	615,420					6.5		%				(1.4)		%				3.7		%				8.8		%
SALES BY GEOGRAPHIC REGION
Americas			$	261,930					$	267,836					(0.4)		%				(2.9)		%				1.1		%				(2.2)		%
Europe			182,461						167,762						(0.3)		%				(0.2)		%				9.3		%				8.8		%
Asia Pacific			225,070						179,822						23.2		%				—		%				2.0		%				25.2		%
Total sales			$	669,461					$	615,420					6.5		%				(1.4)		%				3.7		%				8.8		%

7

NORDSON CORPORATION

RECONCILIATION OF NON-GAAP MEASURES - NET INCOME TO EBITDA (Unaudited)

(Dollars in thousands)

			Three Months Ended
			January 31, 2026						January 31, 2025
Net income			$	133,382					$	94,652
Income taxes			31,119						22,203
Interest expense — net			22,741						25,618
Other income — net			(20,837)						(1,526)
Inventory step-up amortization (1)			—						3,135
Severance and other (1)			—						5,961
Acquisition-related costs (1)			—						1,030
Adjusted operating profit			166,405						151,073
Depreciation and amortization			36,585						37,030
EBITDA (non-GAAP) (2)			$	202,990					$	188,103

(1) Represents non-recurring cost reduction actions as well as fees and non-cash inventory charges associated with acquisitions.

(2) EBITDA is a non-GAAP measure used by management to evaluate the Company's ongoing operations. EBITDA is defined as operating profit plus certain adjustments, such as non-recurring cost reduction actions, fees and non-cash inventory charges associated with acquisitions, plus depreciation and amortization.

8

NORDSON CORPORATION

RECONCILIATION OF NON-GAAP MEASURES - ADJUSTED NET INCOME AND EARNINGS PER SHARE (Unaudited)

(Dollars in thousands)

			Three Months Ended
			January 31, 2026						January 31, 2025
GAAP AS REPORTED
Net income			$	133,382					$	94,652
Diluted earnings per share			$	2.38					$	1.65
Shares outstanding — diluted			56,127						57,486
ADJUSTMENTS
Inventory step-up amortization (1)			$	—					$	3,135
Acquisition costs (1)			—						1,030
Severance and other (1)			—						5,961
Acquisition amortization of intangibles			19,569						19,311
Non-cash gain on minority investment (2)			(22,238)						—
Total adjustments			$	(2,669)					$	29,437
Adjustments net of tax			$	(632)					$	23,844
EPS effect of adjustments			$	(0.01)					$	0.41
NON-GAAP
Adjusted net income (3)			132,750						$	118,496
Adjusted earnings per share (4)			$	2.37					$	2.06

(1) Represents non-recurring cost reduction actions as well as fees and non-cash inventory charges associated with acquisitions.

(2) Represents non-cash gain on minority investment accounted for at fair value.

(3) Adjusted net income is a non-GAAP measure defined as net income plus tax effected adjustments and other discrete tax items.

(4) Adjusted earnings per share is a non-GAAP measure defined as GAAP EPS adjusted for tax effected adjustments and other discrete tax items.

9

NORDSON CORPORATION

RECONCILIATION OF NON-GAAP MEASURES - OPERATING CASH FLOW TO FREE CASH FLOW (Unaudited)

(Dollars in thousands)

			Year to Date
			January 31, 2026						January 31, 2025
Net cash provided by operating activities			$	140,428					$	159,122
Additions to property, plant and equipment			(17,513)						(21,399)
Free cash flow — year to date (1)			$	122,915					$	137,723
Net income — year to date			$	133,382					$	94,652
Non-cash gain on minority investment — after-tax			(16,679)						—
Net income excluding non-cash gain on minority investment — year to date (2)			$	116,703					$	94,652
Free cash flow conversion — year to date (3)			105		%				146		%

(1) Free cash flow is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Net cash provided by operating activities minus Additions to property, plant and equipment.

(2) Net income excluding non-cash gain on minority investment is a non-GAAP measure used by management as an input to the calculation of Free cash flow conversion and is defined as Net income excluding non-cash gains/losses on minority investment.

(3) Free cash flow conversion is a non-GAAP measure used by management to evaluate the Company's ongoing operations and is defined as Free cash flow divided by Net income excluding non-cash gain on minority investment.

Management uses certain non-GAAP measures, such as adjusted net income, adjusted EPS and EBITDA, internally to make strategic decisions, forecast future results, and evaluate the Company's current performance. Given management's use of these non-GAAP measures, the Company believes these measures are important to investors in understanding the Company's current and future operating results as seen through the eyes of management. In addition, management believes these non-GAAP measures are useful to investors in enabling them to better assess changes in the Company's core business across different time periods. Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures to other companies' non-GAAP financial measures, even if they have similar names. Amounts may not add due to rounding.

Contact

Lara Mahoney

Vice President

Investor Relations & Corporate Communications

440.204.9985

Lara.Mahoney@nordson.com

10

FAQ

How did Nordson (NDSN) perform in its fiscal Q1 2026 results?

Nordson reported record fiscal Q1 2026 results with sales of $669 million, up about 9% year-over-year. Net income reached $133 million, and diluted EPS increased to $2.38 from $1.65, reflecting both operational growth and a non-cash gain on a minority investment.

What was Nordson (NDSN) adjusted EPS for Q1 2026 and how did it change?

Adjusted earnings per diluted share for Q1 2026 were $2.37, a first quarter record for Nordson. This compares with adjusted EPS of $2.06 in the prior-year quarter, representing a 15% year-over-year increase after excluding acquisition amortization and a non-cash minority investment gain.

How did Nordson’s (NDSN) business segments perform in Q1 2026?

Industrial Precision Solutions sales were $327 million, up 9%, with EBITDA of $110 million. Medical and Fluid Solutions sales were $193 million, flat year-over-year, but EBITDA rose to $70 million. Advanced Technology Solutions sales climbed to $149 million, up 23%, with EBITDA increasing to $33 million.

What guidance did Nordson (NDSN) provide for fiscal Q2 2026?

For fiscal Q2 2026, Nordson expects sales between $710 million and $740 million. The company also forecasts adjusted earnings in the range of $2.70 to $2.90 per diluted share, reflecting confidence based on higher backlog and broad-based order entry momentum across its segments.

How has Nordson (NDSN) updated its full-year fiscal 2026 outlook?

Nordson increased its full-year fiscal 2026 guidance, now projecting sales of $2,860 to $2,980 million. Adjusted earnings are expected to range from $11.00 to $11.60 per diluted share, supported by record Q1 performance, higher backlog, and strengthening order entry trends in key end markets.

What was Nordson’s (NDSN) EBITDA and margin in Q1 2026?

Nordson reported first quarter 2026 EBITDA of $203 million, a record for the period. This represented 30% of sales, compared with EBITDA of $188 million and a 31% margin in the prior-year quarter, highlighting strong absolute profit growth with slightly lower margin percentage.

Filing Exhibits & Attachments

4 documents

Press Releases

• EX-99.1 EX-99.1 224.1 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 1.7 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 21.1 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 12.2 KB